Bafna Pharmaceuticals Limited logo

Bafna Pharmaceuticals Limited (BAFNAPHARM)

Market Closed
9 Jan, 09:50
MSE MSE
102. 51
+0.39
+0.3819%
- Market Cap
- P/E Ratio
- Div Yield
2,453 Volume
- Eps
102.12
Previous Close
Add Transaction
Day Range
102.5 107.22
Year Range
5.25 184
Want to track BAFNAPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bafna Pharmaceuticals Limited (BAFNAPHARM) Statistics

Valuation metrics

Market Cap -
Enterprise value 242.5M
Trailing P/E (ttm) 51.77
Forward P/E -
PEG ratio 0.52
Price/Sales (ttm) 0.33
Price/Book (mrq) 2.86
Enterprise Value/Revenue 0.33
Enterprise Value/EBITDA 2.54

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.65K
Average volume (90 days) 5.6K

Price summary

52-Week low 5.25
52-Week high 184
Beta -
50-Day moving average 229.78
200-Day moving average 156.54

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 26 Aug 2019

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.06%
Operating margin 0.14%

Operational effectiveness

Return on assets 0.06%
Return on equity 0.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 31.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.98
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.85
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 1.57%
Book value per share (mrq) 35.79

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -